Nasdaq: MDGL
Madrigal Pharmaceuticals insiders
The officers, directors and 10% owners of Madrigal Pharmaceuticals, Inc. who hold the most stock, valued at the live MDGL price.
$396.74
MDGL today −$1.3M (−0.34%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 13
- Their MDGL stock
- $540M
- Market value
- $9.22B
- Held by ranked insiders
- 5.86%
Insiders by value of MDGL holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Rebecca Taub | Director | 452,667 | $180M | 1.95% | 965th |
| 2 | Fred B. Craves | Director | 419,609 | $166M | 1.81% | 1021st |
| 3 | William John Sibold | President and CEO | 197,746 | $78.5M | 0.85% | 1824th |
| 4 | Paul A. Friedman | Director | 187,164 | $74.3M | 0.81% | 1904th |
| 5 | Richard S. Levy | Director | 22,469 | $8.9M | <0.1% | 8091st |
| 6 | Alex G. Howarth | Chief Financial Officer | 18,737 | $7.4M | <0.1% | 10908th |
| 7 | Brian J. Lynch | SVP and General Counsel | 18,221 | $7.2M | <0.1% | 11157th |
| 8 | Remy Sukhija | Chief Commercial Officer | 15,001 | $6.0M | <0.1% | 12845th |
| 9 | Carole Huntsman | Chief Commercial Officer | 12,692 | $5.0M | <0.1% | 14387th |
| 10 | Mardi Dier | EVP and CFO | 12,490 | $5.0M | <0.1% | 12612th |
| 11 | Jacqualyn Fouse | Director | 1,551 | $615K | <0.1% | 10858th |
| 12 | Daniel J. Brennan | Director | 1,371 | $544K | <0.1% | 8006th |
| 13 | John C. Reed | Director | 647 | $257K | <0.1% | 11511th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Madrigal Pharmaceuticals; see each profile for the filing.